1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Orthobiologics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, South Korea
3.1 Orthobiologics Market, South Korea, Revenue ($m), 2018-2033
3.1.1 Bone Grafts and Substitutes Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.2 Bone Growth Stimulators Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.3 Cartilage Repair Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.4 Soft Tissue Biologics Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.5 Viscosupplementation Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.2 Orthobiologics Market, South Korea, Volume (Units), 2018-2033
3.2.1 Bone Grafts and Substitutes Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.2 Bone Growth Stimulators Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.3 Cartilage Repair Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.4 Soft Tissue Biologics Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.5 Viscosupplementation Market, South Korea, Volume (Units), by Segment, 2018-2033
3.3 Orthobiologics Market, South Korea, Average Price ($) , 2018-2033
3.4 Orthobiologics Market, South Korea, Distribution Share by Revenue ($m), 2023
3.5 Orthobiologics Market, South Korea, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in South Korea, Orthobiologics Market
4.1 Sanofi
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 Seikagaku Corp
4.3.1 Company Overview
4.4 Stryker Corp
4.4.1 Company Overview
4.5 Zimmer Biomet Holdings Inc
4.5.1 Company Overview
4.6 Ferring Pharmaceuticals AS
4.6.1 Company Overview
4.7 Smith & Nephew Plc
4.7.1 Company Overview
4.8 LifeNet Health Inc
4.8.1 Company Overview
4.9 AlloSource
4.9.1 Company Overview
6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 Cellumed Raises USD7 Million in Private Placement of Shares
6.2 Partnerships
6.2.1 Dongkook Pharma Enters into Co-Marketing Agreement with Sewon Cellontech
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Distribution Share Analysis
7.1.7 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 2: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 3: Bone Growth Stimulators Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 4: Cartilage Repair Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 5: Soft Tissue Biologics Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 6: Viscosupplementation Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 7: Orthobiologics Market, South Korea, Volume (Units), 2018-2033
Table 8: Bone Grafts and Substitutes Market, South Korea, Volume (Units), 2018-2033
Table 9: Bone Growth Stimulators Market, South Korea, Volume (Units), 2018-2033
Table 10: Cartilage Repair Market, South Korea, Volume (Units), 2018-2033
Table 11: Soft Tissue Biologics Market, South Korea, Volume (Units), 2018-2033
Table 12: Viscosupplementation Market, South Korea, Volume (Units), 2018-2033
Table 13: Orthobiologics Market, South Korea, Average Price ($), 2018-2033
Table 14: Orthobiologics Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2023
Table 15: Orthobiologics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2023
Table 16: Orthobiologics Market Pipeline Products
Table 17: Cellumed Raises USD7 Million in Private Placement of Shares
Table 18: Dongkook Pharma Enters into Co-Marketing Agreement with Sewon Cellontech
Table 19: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 2: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 3: Bone Growth Stimulators Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 4: Cartilage Repair Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 5: Soft Tissue Biologics Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 6: Viscosupplementation Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 7: Orthobiologics Market, South Korea, Volume (Units), 2018-2033
Figure 8: Bone Grafts and Substitutes Market, South Korea, Volume (Units), 2018-2033
Figure 9: Bone Growth Stimulators Market, South Korea, Volume (Units), 2018-2033
Figure 10: Cartilage Repair Market, South Korea, Volume (Units), 2018-2033
Figure 11: Soft Tissue Biologics Market, South Korea, Volume (Units), 2018-2033
Figure 12: Viscosupplementation Market, South Korea, Volume (Units), 2018-2033
Figure 13: Orthobiologics Market, South Korea, Company Share (%) 2023
